Alzai Health Acquired | Healthcare M&A Deal

Alzai Health Corp. has completed the acquisition of Alzai Health, a healthcare IT business in Canada, for $4,000,000. The company is building healthcare technology offerings through an initial public offering structure, combining common shares with warrant-linked financing for growth in healthcare IT. Investors receive units priced at $0.40, with warrants exercisable at $0.60 per warrant share for 24 months, subject to an acceleration right tied to TSX Venture Exchange trading levels. The other acquisition is sized under $10M and is supported by an exclusive agent, with the final long-form prospectus dated April 21, 2026 and a closing expected after regulatory review across British Columbia, Alberta, and Ontario.